The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium Sulfacetamide 9.8% and Sulfur 4.8% · SULFACETAMIDE SODIUM 98 mg/g; SULFUR 48 mg/g · Emulsion · Topical · BioComp Pharma, Inc.
NDC 44523-0748-10 · 285 g in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
price up 35% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| BioComp Pharma, Inc. | SULFACETAMIDE SODIUM 98 mg/g; SULFUR 48 mg/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Sodium Sulfacetamide And Sulfur — NDC 44523-0748-10," retrieved September 3, 2026, https://drugdashboards.com/drug/44523074810.
Free to cite with attribution — see how the data is put together.